TruScreen Group Limited reported that the Dr Sulaiman Al-Habib Medical Group, has installed the first tranche of four TruScreen devices for commercial use, for the screening of cervical cancer in Saudi Arabia. The adoption of TruScreen's screening technology by DSAMG private hospitals will be important reference sites for further market access in neighbouring Middle Eastern nations. This installation follows from the previously announced successful completion of the clinical evaluation by DSAMG network, followed by a successful tender by BettaLife Trading FZC (BettaLife) (Truescreen's distributor in the Middle East).